Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin

WikiDoc Resources for Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin
Articles
Most recent articles on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin Most cited articles on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin Review articles on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin Articles on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin Images of Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin Photos of Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin Podcasts & MP3s on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin Videos on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin
Evidence Based Medicine
Cochrane Collaboration on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin Bandolier on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin TRIP on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin
Clinical Trials
Ongoing Trials on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin at Clinical Trials.gov Trial results on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin Clinical Trials on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin NICE Guidance on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin NHS PRODIGY Guidance FDA on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin CDC on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin
Books
Books on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin
News
Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin in the news Be alerted to news on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin News trends on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin
Commentary
Blogs on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin
Definitions
Definitions of Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin
Patient Resources / Community
Patient resources on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin Discussion groups on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin Patient Handouts on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin Directions to Hospitals Treating Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin Risk calculators and risk factors for Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin
Healthcare Provider Resources
Symptoms of Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin Causes & Risk Factors for Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin Diagnostic studies for Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin Treatment of Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin
Continuing Medical Education (CME)
CME Programs on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin
International
Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin en Espanol Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin en Francais
Business
Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin in the Marketplace Patents on Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin
Experimental / Informatics
List of terms related to Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin

How to edit trial information: Log in, click on the word [edit] to the right of the section you would like to edit, type in the appropriate information, click save page at the bottom when you are done. The template is the minimum elements required by the World Health Organization. You can add additional sections. More help to add a trial here.

Complete Title of Study

Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin

Study Acronym (The trial's abbreviation if there is one)

None reported

Principal Investigator, Co-investigators, and Collaborating Institutions

None reported

Overview of Trial

None reported

Disease State(s) Studied (e.g. acute MI, breast cancer, etc.)

None reported

Study Phase (e.g. Phase I,II,III,IV) Study Phases are defined here

None reported

Study Design (e.g. multicenter, randomized, double blind, placebo controlled)

None reported

Study Arms and How They Were Treated (Intervention) (Explanation here)

None reported

Primary Pre-Specified Endpoint

None reported

Secondary Endpoints

None reported

Inclusion Criteria

None reported

Exclusion Criteria

None reported

Outcome: Primary endpoint (Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available)

None reported

Outcome: Secondary endpoint (Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available)

None reported

Outcome: Exploratory endpoints (Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available)

None reported

Outcome: Safety endpoints (Report both relative risk and absolute risk as well as number needed to harm if available)

None reported

Conclusions of the Investigators (Quote the investigators conclusions here)

None reported

Commentary, Discussion and Limitations of the Trial (Anyone can add comments)

None reported

Slides

None reported

Video Commentary

None reported

References (How to insert a reference)

None reported

External sites for further information (How to insert links)

None reported

Ages

__ years to ___ years

Gender (Indicate whether men, women or both were enrolled)

None reported

Accepts Healthy Volunteers (Answer yes or no)

None reported

Enrollment Period (Study start and end date)

None reported

Recruitment Status (explanation)

None reported

Enrollment (Total number of patients enrolled)

None reported

Study Sponsor (e.g. Investigator initiated or company name)

None reported (this may not have yet been ascertained)

Source of Data (Where is this data on this page coming from: publication, principal investigator, or co-investigator)

None reported

The content of the clinical trial wiki consists of fields that have been suggested by the World Health Organization and wwww.clinicaltrials.gov.